8 completed, 1 active not recruiting, 1 withdrawn. 2 Phase 1, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Tetec AG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non-interventional Study in Pediatric Patients Treated With NOVOCART Inject in the Knee NOVOCART Inject - Cartilage Disease | Withdrawn | Tetec AG | 2025-05-01 | 2025-09-19 | ||
| Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis CLS12311 low, CLS12311 medium, CLS12311 high - Relapsing-remitting Multiple Sclerosis (RRMS) | Phase 1 | Completed | Cellerys AG | 11 | 2024-06-18 | 2026-06-08 |
| Non-interventional Study With NOVOCART® Basic in Patients Treated for Cartilage Defects in the Knee With MAC MAC with NOVOCART Basic - Cartilage Diseases | Completed | Tetec AG | 41 | 2018-04-09 | 2020-04-02 | |
| NOVOCART® Inject Plus for Cartilage Defects of the Knee NOVOCART® Inject plus - Cartilage Defects of the Knee | Phase 3 | Completed | Tetec AG | 100 | 2017-10-10 | 2024-08-14 |
| Non-interventional Study With NOVOCART® 3D for the Treatment of Cartilage Defects of the Knee in Pediatric Patients NOVOCART 3D - Cartilage Disease | Active not recruiting | Tetec AG | 42 | 2017-04-25 | 2025-05-14 | |
| Non-interventional Study With NOVOCART® Inject in the Reconstruction of the Knee Cartilage Defects Cartilage Disease | Completed | Tetec AG | 245 | 2015-12-01 | 2019-12-03 | |
| Non-Interventional Study to Evaluate Safety and Efficacy of NOVOCART 3D in Patients With Cartilage Defects NOVOCART 3D - Cartilage Diseases | Completed | Tetec AG | 81 | 2015-06-01 | 2019-12-03 | |
| Observational Study With NOVOCART® Inject in the Reconstruction of the Hip Joint With Full Thickness Cartilage Defects Cartilage Disease | Completed | Tetec AG | 21 | 2014-12-01 | 2019-12-06 | |
| Phase III Study to Evaluate Safety and Effectiveness of NOVOCART 3D Plus vs. Microfracture in Knee Cartilage Defects NOVOCART® 3D plus, Microfracture - Traumatic Articular Cartilage Defects in the Knee Joint | Phase 3 | Completed | Tetec AG | 263 | 2013-05-01 | 2023-11-24 |
| Safety and Efficacy With NOVOCART® Disc Plus (ADCT) for the Treatment of Degenerative Disc Disease in Lumbar Spine NOVOCART® Disc plus, NOVOCART® Disc basic - Intervertebral Disc Displacement, Intervertebral Disc Degeneration | Phase 1 / Phase 2 | Completed | Tetec AG | 120 | 2012-08-01 | 2021-10-12 |
Cartilage Diseases (6) · Intervertebral Disc Degeneration (1) · Intervertebral Disc Displacement (1) · Low Back Pain (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Mycobacterium avium-intracellulare Infection (1)
Germany (10) · Switzerland (4) · Czechia (3) · Austria (2) · Hungary (2) · Lithuania (2) · France (1) · Italy (1) · Latvia (1) · Poland (1) · United Kingdom (1)
Alexandra Kirner, PhD (1) · Bernhard Waibl, MD (1) · Hans-Joerg Meisel, Professor (1) · Klaus-Peter Guenther, Prof. MD (1) · Peter Angele, Prof. (1) · Peter Angele, Prof. Dr. (1) · Peter Angele, Prof. MD (1) · Philipp Niemeyer, MD (1)
PMID 38501741, PMID 26920137, PMID 35354310, PMID 40778441
2015 (1)